127 related articles for article (PubMed ID: 16765529)
1. Prospective evaluation of quality of life after interstitial brachytherapy for localized prostate cancer.
Caffo O; Fellin G; Bolner A; Coccarelli F; Divan C; Frisinghelli M; Mussari S; Ziglio F; Malossini G; Tomio L; Galligioni E
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):31-7. PubMed ID: 16765529
[TBL] [Abstract][Full Text] [Related]
2. A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.
Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
Jpn J Clin Oncol; 2008 Jul; 38(7):480-5. PubMed ID: 18621847
[TBL] [Abstract][Full Text] [Related]
3. Impact of post-implant dosimetric parameters on the quality of life of patients treated with low-dose rate brachytherapy for localised prostate cancer: results of a single-institution study.
Veccia A; Caffo O; Fellin G; Mussari S; Ziglio F; Maines F; Tomio L; Galligioni E
Radiat Oncol; 2015 Jun; 10():130. PubMed ID: 26054532
[TBL] [Abstract][Full Text] [Related]
4. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer.
Lee WR; McQuellon RP; Case LD; deGuzman AF; McCullough DL
J Urol; 1999 Aug; 162(2):403-6. PubMed ID: 10411047
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
6. Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function.
Chen RC; Clark JA; Talcott JA
J Clin Oncol; 2009 Aug; 27(24):3916-22. PubMed ID: 19620493
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer.
Roeloffzen EM; Lips IM; van Gellekom MP; van Roermund J; Frank SJ; Battermann JJ; van Vulpen M
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1054-60. PubMed ID: 20097486
[TBL] [Abstract][Full Text] [Related]
8. Recall of pretreatment symptoms among men treated with radiotherapy for prostate cancer.
Fransson P
Acta Oncol; 2005; 44(4):355-61. PubMed ID: 16120544
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150.
Vordermark D; Noe M; Markert K; Wulf J; Müller G; Bratengeier K; Beckmann G; Baier F; Guckenberger M; Schiefelbein F; Schön G; Flentje M; Baier K
Radiother Oncol; 2009 May; 91(2):217-24. PubMed ID: 19136175
[TBL] [Abstract][Full Text] [Related]
10. A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancer.
Ash D; Bottomley D; Al-Qaisieh B; Carey B; Gould K; Henry A
Radiother Oncol; 2007 Aug; 84(2):135-9. PubMed ID: 17604140
[TBL] [Abstract][Full Text] [Related]
11. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: a prospective longitudinal study.
Namiki S; Satoh T; Baba S; Ishiyama H; Hayakawa K; Saito S; Arai Y
Urology; 2006 Dec; 68(6):1230-6. PubMed ID: 17141839
[TBL] [Abstract][Full Text] [Related]
12. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia.
Van Vulpen M; De Leeuw JR; Van Gellekom MP; Van Der Hoeven J; De Graeff A; Van Moorselaar RJ; Van Der Tweel I; Hofman P; Lagendijk JJ; Battermann JJ
Int J Hyperthermia; 2003; 19(4):402-13. PubMed ID: 12850926
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05.
Feigenberg SJ; Lee WR; Desilvio ML; Winter K; Pisansky TM; Bruner DW; Lawton C; Morton G; Baikadi M; Sandler H
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):956-64. PubMed ID: 15989995
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of quality of life of patients receiving treatment for prostate cancer.
Eller LS; Lev EL; Gejerman G; Colella J; Esposito M; Lanteri V; Scheuch J; Munver R; Lane P; Junchaya C; Alves L; Galli B; Watson R; Sawczuk I
Nurs Res; 2006; 55(2 Suppl):S28-36. PubMed ID: 16601630
[TBL] [Abstract][Full Text] [Related]
15. Long-term rectal function after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen ZA; Gutman S; Lief J
Cancer J; 2007; 13(2):95-104. PubMed ID: 17476137
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life after radical prostatectomy and low-dose-rate brachytherapy for localized prostate cancer.
Wyler SF; Engeler DS; Seelentag W; Ries G; Schmid HP
Urol Int; 2009; 82(1):17-23. PubMed ID: 19172091
[TBL] [Abstract][Full Text] [Related]
17. Patient-reported long-term rectal function after permanent interstitial brachytherapy for clinically localized prostate cancer.
Orio PF; Merrick GS; Galbreath RW; Butler WM; Lief J; Wallner KE
Brachytherapy; 2012; 11(5):341-7. PubMed ID: 22561216
[TBL] [Abstract][Full Text] [Related]
18. A prospective analysis of patient-reported quality of life after prostate brachytherapy.
Lee WR; McQuellon RP; McCullough DL
Semin Urol Oncol; 2000 May; 18(2):147-51. PubMed ID: 10875457
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial.
Chen RC; Zhang Y; Chen MH; McMahon E; Loffredo M; McPherson CP; Nguyen AU; Nguyen PL; D'Amico AV
BJU Int; 2012 Dec; 110(11):1690-5. PubMed ID: 22502770
[TBL] [Abstract][Full Text] [Related]
20. Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. A survey by a self-administered questionnaire.
Caffo O; Fellin G; Graffer U; Luciani L
Cancer; 1996 Sep; 78(5):1089-97. PubMed ID: 8780548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
